Cancer NetworkOriginal article
<![CDATA[Defining the Role of Neoadjuvant Radiation in Cholangiocarcinoma]]>
ConferencelirafugratinibNeutral
AI Analysis
Summary
Dr. Ethan B. Ludmir discussed neoadjuvant radiation approaches, advanced treatment techniques, the HYPERION CCA trial, and lirafugratinib in cholangiocarcinoma at a cancer medicine conference.
Clinical Trial Data
Importance:3/10
Sentiment:
0.00
cholangiocarcinomaneoadjuvant radiationHYPERION CCA trialoncologyconference discussion
Read the original article
Published by Cancer Network on September 26, 2026 4:00 PM
